p38β MAP Kinase as a Therapeutic Target for Pancreatic Cancer

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

(2011) L Khoja et al.   BRITISH JOURNAL OF CANCER

Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: Part 3

(2010) Akira Nakao et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Plectin-1 as a Novel Biomarker for Pancreatic Cancer

(2010) D. Bausch et al.   CLINICAL CANCER RESEARCH

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

(2010) Puneet Chopra et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The three-dimensional structure of MAP kinase p38β: different features of the ATP-binding site in p38β compared with p38α

(2009) Sangita B. Patel et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity

(2008) R. J. Hill et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS